Monkeypox Bill Provides Crucial Steps Toward Equitable Access to Testing

IDSA applauds new legislation introduced by Rep. Sean Patrick Maloney (D-NY) to ensure monkeypox testing is available at no cost to the public.

Monkeypox Public Health Emergency Should Grant Flexibility to Expand Treatment and Vaccine Access

IDSA and HIVMA support the Biden Administration’s decision to declare the monkeypox outbreak a public health emergency.

IDSA and HIVMA Applaud New Administration Monkeypox Coordinators, Call for Funding and Improved Vaccine Supply and Access

As monkeypox cases top more than 5,800 across 48 states, there is no time to waste.

IDSA Statement on Increase in Monkeypox Vaccine Supply

Today’s U.S. Department of Health and Human Services announcement that nearly 800,000 additional doses of the monkeypox vaccine are now available for distribution is a welcome development, but much more is urgently needed.

IDSA/HIVMA Support Rapid CDC Response to Monkeypox Treatment Access Issues

IDSA and HIVMA appreciate the CDC’s swift action in responding to health care provider concerns regarding the significant procedural barriers required to obtain tecovirimat, or TPOXX, through the Expanded Access for Investigational New Drug program.

House Appropriations Committee Advances Bill With Federal Funding Increases for HIV Programs

HIVMA is encouraged that funding for key HIV programs has increased in the U.S. House of Representatives Appropriations Committee’s funding bill for Labor, Health and Human Services programs for fiscal year 2023.

IDSA and HIVMA Welcome Administration’s Commitment to Bolstering Monkeypox Testing and Vaccination

Increasing access to monkeypox testing and expanding vaccination against infection to people at high risk are needed and welcome steps in efforts to control spread and minimize symptoms.

Supreme Court Decision Overturning Roe v. Wade Threatens Sanctity of Provider-Patient Relationship

IDSA and HIVMA condemn the U.S. Supreme Court decision overturning Roe v. Wade that sanctions government interference in patient autonomy and care and threatens the sanctity of the provider-patient relationship.

Health Care Providers Must Encourage Equitable Access to COVID-19 Antiviral Treatments

People who may be most in need of antiviral treatment for COVID-19 may not be receiving it because of where they live, according to a recent report from the U.S. Centers for Disease Control and Prevention.

IDSA/HIVMA Statement on Monkeypox Outbreak: Stigma Has No Place in Public Health

IDSA and HIVMA echo the concern expressed by UNAIDS about the use of racist and homophobic language regarding the current monkeypox outbreak.

President Prioritizes Funding to End the HIV Epidemic in the U.S. FY 2023 Budget Plan

In his budget plan for fiscal year 2023, President Joe Biden calls for important investments to grow the Ending the HIV Epidemic initiative and to create a National PrEP Program that will dramatically increase access to PrEP and reach many more of the 1.2 million people who could benefit from it.

HIVMA Applauds President’s Budget to Create National PrEP Program

HIVMA applauds President Biden for calling for the creation of a national PrEP program with an investment of $9.8 billion in mandatory funding over 10 years in his fiscal year 2023 budget proposal.